These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 20502442

  • 1. MYC-microRNA-9-metastasis connection in breast cancer.
    Almeida MI, Reis RM, Calin GA.
    Cell Res; 2010 Jun; 20(6):603-4. PubMed ID: 20502442
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M, Seger D, Kreizman T, Badikhi D, Margalit R, Eilam R, Degani H.
    Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
    [Abstract] [Full Text] [Related]

  • 5. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    DiFeo A, Narla G, Camacho-Vanegas O, Nishio H, Rose SL, Buller RE, Friedman SL, Walsh MJ, Martignetti JA.
    Oncogene; 2006 Sep 28; 25(44):6026-31. PubMed ID: 16702959
    [Abstract] [Full Text] [Related]

  • 6. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
    Yang SZ, Kohno N, Yokoyama A, Kondo K, Hamada H, Hiwada K.
    Int J Oncol; 2001 Mar 28; 18(3):541-8. PubMed ID: 11179484
    [Abstract] [Full Text] [Related]

  • 7. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N, Hill AD, Young LS.
    J Mol Endocrinol; 2006 Dec 28; 37(3):377-90. PubMed ID: 17170079
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S, Goldstein RH, Scepansky EM, Rosenblatt M.
    Cancer Res; 2009 Nov 15; 69(22):8742-51. PubMed ID: 19887617
    [Abstract] [Full Text] [Related]

  • 9. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH, Sun X, Meng XW, Lv ZW, Du YJ, Zhu Y, Chen J, Kong DX, Jin SZ.
    Oncol Rep; 2010 Oct 15; 24(4):1093-9. PubMed ID: 20811694
    [Abstract] [Full Text] [Related]

  • 10. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY, Wang ZM, Li-Chen, Wang BL, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2010 Feb 15; 119(3):601-12. PubMed ID: 19301122
    [Abstract] [Full Text] [Related]

  • 11. Involvement of microRNAs in breast cancer.
    Adams BD, Guttilla IK, White BA.
    Semin Reprod Med; 2008 Nov 15; 26(6):522-36. PubMed ID: 18951334
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K, Baudino TA.
    Mol Cancer Res; 2007 Dec 15; 5(12):1296-303. PubMed ID: 18171987
    [Abstract] [Full Text] [Related]

  • 13. Getting at MYC through RAS.
    Bachireddy P, Bendapudi PK, Felsher DW.
    Clin Cancer Res; 2005 Jun 15; 11(12):4278-81. PubMed ID: 15958607
    [No Abstract] [Full Text] [Related]

  • 14. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K, Akcali KC, Ozturk M.
    Oncol Rep; 2006 Mar 15; 15(3):701-7. PubMed ID: 16465433
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP, Mirza S, Sharma G, Prashad R, DattaGupta S, Rath G, Ralhan R.
    Life Sci; 2008 Aug 29; 83(9-10):318-25. PubMed ID: 18662704
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ.
    Cancer Res; 2007 Oct 15; 67(20):9762-70. PubMed ID: 17942906
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
    Ren Y, Chan HM, Li Z, Lin C, Nicholls J, Chen CF, Lee PY, Lui V, Bacher M, Tam PK.
    Oncogene; 2004 May 20; 23(23):4146-54. PubMed ID: 15064733
    [Abstract] [Full Text] [Related]

  • 18. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G, Chen J, Liu L, Wang Y, Li L, Qin Y, Zhou Q.
    Neoplasma; 2006 May 20; 53(6):530-7. PubMed ID: 17167724
    [Abstract] [Full Text] [Related]

  • 19. Regulation of N-myc gene expression in human neuroblastoma.
    Iyer J, Korones DN, Ikegaki N, Kennett RH, Frantz CN.
    Prog Clin Biol Res; 1991 May 20; 366():55-64. PubMed ID: 2068172
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Löwik C.
    J Bone Miner Res; 2001 Jun 20; 16(6):1077-91. PubMed ID: 11393785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.